Selenium as a Potential Treatment for Moderately-ill, Severely-ill, and Critically-ill COVID-19 Patients
et al., NCT04869579, SeCOVID, NCT04869579, Dec 2021
Estimated 100 patient selenium late treatment RCT with results not reported over 3 years after estimated completion.
Ghoweba et al., 15 Dec 2021, Double Blind Randomized Controlled Trial, USA, trial NCT04869579 (history) (SeCOVID).
Contact: mohamed.ghoweba@christushealth.org.